Catena Biosciences
Using protein coupling to build new therapies
Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.
- Website
- catenabiosciences.com
- City
- San Francisco
- Country
- United States
- YC batch
- Summer 2021
- Team
- 7 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run catenabiosciences.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Catena Biosciences across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Catena Biosciences's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
